Prescribers & Clinics
Resources and governance insight for clinicians and healthcare providers.
Prescribers & Clinics · page 3
- Prescribers & Clinics
Collapsed Cannim Sees Liquidators Target $32m in Voidable Transactions as UK Creditors Face Enforcement Gap
Collapsed international cannabis operator Cannim has officially been placed into liquidation following a failed sales process, seeing its myriad of creditors vie for their share of the tens of millions of dollars now reportedly outstanding.
- Medical Cannabis
Medical Cannabis Police Guidance Published, But No Training Programme Planned
Medical cannabis once again found itself at the centre of the UK mainstream media’s attention this week, following a troubling coroner’s finding that a prescription ‘contributed to’ a patient’s death.
- Cultivation
Future-Ready: Why Pure Is Building the Cannabis Company Traditional Industry Will Want to Buy Into
Last year, as other European cannabis markets looked to be retreating from their ambitious progress in 2024, Switzerland accelerated its plans for cannabis reform.
- Medical Cannabis
Is Europe Moving Away From Cannabis Flower? – Why Companies Are Betting on CE-Certified Devices
Last week, we reported on an emerging trend in the European medical cannabis industry, which is seeing regulators in incoming markets favour alternative modes of administration, challenging the ubiquity of dried flower.
- Medical Cannabis
UK’s First Medical Cannabis Legal Helpline Launches as Patients Navigate New Police Guidance
UK medical cannabis clinic Releaf has launched a new 24/7 on-demand legal support service for its prescribed patients, helping navigate common issues with their medication with professional guidance.
- Industry Trends
In the UK’s Medical Cannabis Market, the Winner Takes All
Earlier this week, we looked at the dramatic shifts in the UK medical cannabis flower market over the last three years.
- Industry Trends
What Is Really Going on in the UK’s Medical Cannabis Market? (New 2025 Data Analysis)
The UK’s medical cannabis industry has nearly tripled in size since 2022, according to new Freedom of Information data offering the most comprehensive look into what is being prescribed in the UK to date.
- Industry Trends
First Practical Medical Cannabis Oil Dosing Guide Published for UK Clinicians
Originally published on Cannabis Health The Medical Cannabis Clinicians Society (MCCS) has published what it describes as a crucial step forward for standardised prescribing in the UK, a comprehensive guide establishing evidence-based dosing protocols for cannabis oils.
- Clinical Research
Cannabis Health Symposium 2025 – Key Takeaways Part 2
The afternoon sessions at Tuesday’s inaugural Cannabis Health Symposium 2025 moved beyond the fundamentals of cannabis medicine and its potential, to the practical realities of prescribing this relatively new medicine in the UK.
- Clinical Research
Cannabis Health Symposium 2025 – Key Takeaways Part 1
On Tuesday, November 25, nearly 200 healthcare professionals, patient advocates, cannabis educators, and industry leaders converged on London’s Conway Hall for the inaugural Cannabis Health Symposium.
- Prescribers & Clinics
High-THC Leads Growth as Australia Tightens TGA Prescribing Rules
The medical cannabis industries in Australia and New Zealand are continuing to evolve rapidly, with both markets showing signs of maturation, regulatory recalibration, and expanding export ambitions, according to new data.
- Prescribers & Clinics
Airo Brands Announces CE-Certified Medical Inhalation Device in Partnership with SOMAÍ
Airo Brands, a US multi-state CPG company focused on proprietary cannabis products, in partnership with Jupiter Research LLC, has received regulatory approval for its CE-marked Class IIa medical handheld liquid inhalation device, the Airo Medical Inhalation System, across Europe and Australia.
